Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-06-17FDA Approved: BYETTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for BYETTA (exenatide) filed by AstraZeneca Pharmaceuticals LP.
-
CLINICAL_TRIALS trial_result · 2021-06-16Clinical Trial Update: Efficacy and Safety of EGT0001442 in Patients With Type 2 Diabetes Mellitus [Phase 2]
Phase 2 trial update on the efficacy and safety of EGT0001442 in patients with type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2021-06-15Clinical Trial Update: Effects and Safety of OPK-88003 Dose Escalation in Type 2 Diabetes Subjects [Phase 2]
Phase 2 trial update on dose escalation of OPK-88003 in adults with Type 2 Diabetes: results completed and posted.
-
CLINICAL_TRIALS trial_result · 2021-06-15Clinical Trial Update: Effect of GLP-1 on Angiogenesis [Phase 4]
Phase 4 clinical trial update studying the effect of GLP-1 on angiogenesis in type 2 diabetes patients.
-
FDA label_change · 2021-06-11FDA Approved: SYNJARDY — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for Synjardy (empagliflozin and metformin hydrochloride) submitted by Boehringer Ingelheim Pharmaceu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-06-11FDA Approved: SYNJARDY XR — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for SYNJARDY XR, a fixed-dose combination of empagliflozin and metformin hydrochloride.
-
FDA approval · 2021-06-11FDA Approved: TRIJARDY XR — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for TRIJARDY XR (empagliflozin, linagliptin, metformin hydrochloride) from Boehringer Ingelheim …
-
CLINICAL_TRIALS trial_result · 2021-06-11Clinical Trial Update: Complement and Cardiovascular Risk in Adolescents
Trial update on complement system and cardiovascular risk in adolescents with cardiovascular disease and type 2 diabetes; study completed wi…
-
CLINICAL_TRIALS trial_result · 2021-06-11Clinical Trial Update: DECREASE: Dapagliflozin Plus Exenatide on Central REgulation of Appetite in diabeteS typE 2 [Phase 4]
Phase 4 trial studying dapagliflozin plus exenatide on central regulation of appetite in type 2 diabetes and obesity has completed.
-
CLINICAL_TRIALS withdrawal · 2021-06-10Clinical Trial Update: Effects of DPP4 Inhibition on COVID-19 [Phase 4]
A Phase 4 trial examining the effects of DPP-4 inhibition on COVID-19 has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-06-10Clinical Trial Update: The Effect Effect of Empagliflozin on Oxidative Stress in Patients With Type 2 Diabetes [Phase 2]
A Phase 2 trial assessing the effect of empagliflozin on oxidative stress in patients with Type 2 diabetes has been completed.
-
CLINICAL_TRIALS trial_result · 2021-06-09Clinical Trial Update: A Randomized, Placebo-controlled Clinical Trial of Teneligliptin as Quadruple Oral Combination Therapy for Type 2 DM After Failure of an Oral Triple Anti-diabetic Regimen [Phase 4]
Phase 4 randomized trial evaluating teneligliptin added to quadruple oral therapy after failure of triple therapy in type 2 diabetes mellitu…
-
CLINICAL_TRIALS trial_result · 2021-06-08Clinical Trial Update: Cholecalciferol on Depressive Symptoms in Type 2 Diabetes Mellitus Patients [Phase 2]
Phase 2 clinical trial exploring cholecalciferol (vitamin D3) for depressive symptoms in patients with type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2021-06-07Clinical Trial Update: Safety and Efficacy of Antidiabetic Drugs in Recently Diagnosed Patients With Type 2 Diabetes [Phase 4]
Phase 4 clinical trial update evaluating safety and efficacy of antidiabetic drugs in recently diagnosed patients with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2021-06-07Clinical Trial Update: Performance Evaluation of an Advanced Algorithm With CGM in Adults, Adolescents, and Pediatrics [NA]
A completed clinical trial evaluating an advanced CGM-based performance algorithm in adults, adolescents, and pediatric patients with diabet…
-
CLINICAL_TRIALS trial_result · 2021-06-04Clinical Trial Update: Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes Subjects [Phase 3]
Phase 3 trial comparing Bexagliflozin to Sitagliptin as add-on to metformin in type 2 diabetes completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-06-03Clinical Trial Update: Impact of Pharmacy Clinic on Diabetes Management [NA]
A completed clinical trial assessing the impact of a pharmacy clinic on management of Type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19 [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Dipeptidyl Peptidase-4 inhibitors (e.g., linagliptin) in diabetic patients with establis…
-
CLINICAL_TRIALS trial_result · 2021-06-01Clinical Trial Update: Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASH [Phase 2]
Phase 2 trial evaluating MET409 alone or with empagliflozin in patients with type 2 diabetes and nonalcoholic steatohepatitis (NASH).
-
CLINICAL_TRIALS trial_result · 2021-05-28Clinical Trial Update: Randomized Study Comparing Metabolic Surgery With Intensive Medical Therapy to Treat Diabetic Kidney Disease [Phase 2]
A Phase 2 randomized study compares metabolic surgery with intensive medical therapy for diabetic kidney disease.
-
CLINICAL_TRIALS trial_result · 2021-05-28Clinical Trial Update: Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection [Phase 1]
Phase 1 study evaluating drug-drug interaction between bexagliflozin and exenatide injection in type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2021-05-28Clinical Trial Update: The Study Will Evaluate Average 24-hr Sodium Excretion During Dapagliflozin Treatment in Patients With Type 2 Diabetes Mellitus With Preserved or Impaired Renal Function or Non-diabetics With Impaired Renal Function. [Phase 4]
Phase 4 trial evaluating average 24-hour sodium excretion during dapagliflozin treatment in adults with type 2 diabetes and varying renal fu…
-
CLINICAL_TRIALS trial_result · 2021-05-27Clinical Trial Update: Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects [Phase 3]
Phase 3 trial comparing Bexagliflozin to Glimepiride as add-on to metformin in type 2 diabetes; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2021-05-26Clinical Trial Update: Study of Two Doses of Oral HDV-Insulin and Placebo With Background Metformin Treatment in Patients With Type 2 Diabetes Mellitus [Phase 2, Phase 3]
Phase 2/3 trial evaluating two doses of oral HDV-Insulin versus placebo with metformin in type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2021-05-25Clinical Trial Update: A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial comparing LY2963016 to Lantus in adult Chinese participants with type 2 diabetes completed; results posted in 2021.